ID   GNAS2_BOVIN             Reviewed;         394 AA.
AC   P04896; Q0II85; Q3SZE7;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   25-OCT-2017, entry version 177.
DE   RecName: Full=Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;
DE   AltName: Full=Adenylate cyclase-stimulating G alpha protein;
GN   Name=GNAS; Synonyms=GNAS1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3080331; DOI=10.1016/0014-5793(86)80164-8;
RA   Nukada T., Tanabe T., Takahashi H., Noda M., Hirose T., Inayama S.,
RA   Numa S.;
RT   "Primary structure of the alpha-subunit of bovine adenylate cyclase-
RT   stimulating G-protein deduced from the cDNA sequence.";
RL   FEBS Lett. 195:220-224(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3081893; DOI=10.1073/pnas.83.5.1251;
RA   Robishaw J.D., Russell D.W., Harris B.A., Smigel M.D., Gilman A.G.;
RT   "Deduced primary structure of the alpha subunit of the GTP-binding
RT   stimulatory protein of adenylate cyclase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1251-1255(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Hypothalamus, and Kidney;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 69-90.
RX   PubMed=3015900;
RA   Robishaw J.D., Smigel M.D., Gilman A.G.;
RT   "Molecular basis for two forms of the G protein that stimulates
RT   adenylate cyclase.";
RL   J. Biol. Chem. 261:9587-9590(1986).
RN   [5]
RP   FUNCTION.
RX   PubMed=2022671;
RA   Tang W.J., Krupinski J., Gilman A.G.;
RT   "Expression and characterization of calmodulin-activated (type I)
RT   adenylylcyclase.";
RL   J. Biol. Chem. 266:8595-8603(1991).
RN   [6]
RP   CLEAVAGE OF INITIATOR METHIONINE, PALMITOYLATION AT GLY-2 AND CYS-3,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12574119; DOI=10.1093/emboj/cdg095;
RA   Kleuss C., Krause E.;
RT   "Galpha(s) is palmitoylated at the N-terminal glycine.";
RL   EMBO J. 22:826-832(2003).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF ISOFORM GNAS-2 IN COMPLEX
RP   WITH GTP ANALOG; MAGNESIUM IONS AND CATALYTIC DOMAINS OF ADCY2 AND
RP   ADCY5, MISCELLANEOUS, AND INTERACTION WITH ADCY2 AND ADCY5.
RX   PubMed=9395396; DOI=10.1126/science.278.5345.1943;
RA   Sunahara R.K., Tesmer J.J.G., Gilman A.G., Sprang S.R.;
RT   "Crystal structure of the adenylyl cyclase activator Gsalpha.";
RL   Science 278:1943-1947(1997).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF COMPLEX WITH GTP ANALOG;
RP   MAGNESIUM IONS AND CATALYTIC DOMAINS OF ADCY2 AND ADCY5,
RP   MISCELLANEOUS, AND INTERACTION WITH ADCY2 AND ADCY5.
RX   PubMed=9417641; DOI=10.1126/science.278.5345.1907;
RA   Tesmer J.J.G., Sunahara R.K., Gilman A.G., Sprang S.R.;
RT   "Crystal structure of the catalytic domains of adenylyl cyclase in a
RT   complex with Gsalpha.GTPgammaS.";
RL   Science 278:1907-1916(1997).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF COMPLEX WITH GTP ANALOG;
RP   MAGNESIUM IONS AND CATALYTIC DOMAINS OF ADCY2 AND ADCY5,
RP   MISCELLANEOUS, AND INTERACTION WITH ADCY2 AND ADCY5.
RX   PubMed=10427002; DOI=10.1126/science.285.5428.756;
RA   Tesmer J.J.G., Sunahara R.K., Johnson R.A., Gosselin G., Gilman A.G.,
RA   Sprang S.R.;
RT   "Two-metal-ion catalysis in adenylyl cyclase.";
RL   Science 285:756-760(1999).
RN   [10] {ECO:0000244|PDB:1CS4, ECO:0000244|PDB:1CUL}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) IN COMPLEX WITH GTP ANALOG;
RP   MAGNESIUM IONS AND CATALYTIC DOMAINS OF ADCY2 AND ADCY5,
RP   MISCELLANEOUS, INTERACTION WITH ADCY2 AND ADCY5, AND FUNCTION.
RX   PubMed=11087399; DOI=10.1021/bi0015562;
RA   Tesmer J.J., Dessauer C.W., Sunahara R.K., Murray L.D., Johnson R.A.,
RA   Gilman A.G., Sprang S.R.;
RT   "Molecular basis for P-site inhibition of adenylyl cyclase.";
RL   Biochemistry 39:14464-14471(2000).
RN   [11] {ECO:0000244|PDB:1TL7, ECO:0000244|PDB:1U0H}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH GTP ANALOG;
RP   MAGNESIUM IONS AND CATALYTIC DOMAINS OF ADCY2 AND ADCY5,
RP   MISCELLANEOUS, INTERACTION WITH ADCY2 AND ADCY5, AND FUNCTION.
RX   PubMed=15591060; DOI=10.1074/jbc.M409076200;
RA   Mou T.C., Gille A., Fancy D.A., Seifert R., Sprang S.R.;
RT   "Structural basis for the inhibition of mammalian membrane adenylyl
RT   cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-
RT   triphosphate.";
RL   J. Biol. Chem. 280:7253-7261(2005).
RN   [12] {ECO:0000244|PDB:2GVD, ECO:0000244|PDB:2GVZ}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) IN COMPLEX WITH GTP ANALOG;
RP   MANGANESE IONS AND CATALYTIC DOMAINS OF ADCY2 AND ADCY5,
RP   MISCELLANEOUS, INTERACTION WITH ADCY2 AND ADCY5, AND FUNCTION.
RX   PubMed=16766715; DOI=10.1124/mol.106.026427;
RA   Mou T.C., Gille A., Suryanarayana S., Richter M., Seifert R.,
RA   Sprang S.R.;
RT   "Broad specificity of mammalian adenylyl cyclase for interaction with
RT   2',3'-substituted purine- and pyrimidine nucleotide inhibitors.";
RL   Mol. Pharmacol. 70:878-886(2006).
RN   [13] {ECO:0000244|PDB:3C14, ECO:0000244|PDB:3C15, ECO:0000244|PDB:3C16, ECO:0000244|PDB:3MAA}
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) IN COMPLEX WITH GTP ANALOG;
RP   MAGNESIUM IONS AND CATALYTIC DOMAINS OF ADCY2 AND ADCY5,
RP   MISCELLANEOUS, INTERACTION WITH ADCY2 AND ADCY5, AND FUNCTION.
RX   PubMed=19243146; DOI=10.1021/bi802122k;
RA   Mou T.C., Masada N., Cooper D.M., Sprang S.R.;
RT   "Structural basis for inhibition of mammalian adenylyl cyclase by
RT   calcium.";
RL   Biochemistry 48:3387-3397(2009).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins)
CC       function as transducers in numerous signaling pathways controlled
CC       by G protein-coupled receptors (GPCRs). Signaling involves the
CC       activation of adenylyl cyclases, resulting in increased levels of
CC       the signaling molecule cAMP (PubMed:2022671, PubMed:9395396,
CC       PubMed:11087399, PubMed:15591060, PubMed:16766715,
CC       PubMed:19243146). GNAS functions downstream of several GPCRs,
CC       including beta-adrenergic receptors. Stimulates the Ras signaling
CC       pathway via RAPGEF2 (By similarity).
CC       {ECO:0000250|UniProtKB:P63092, ECO:0000269|PubMed:11087399,
CC       ECO:0000269|PubMed:2022671, ECO:0000269|PubMed:9395396,
CC       ECO:0000305|PubMed:15591060, ECO:0000305|PubMed:16766715,
CC       ECO:0000305|PubMed:19243146}.
CC   -!- SUBUNIT: Heterotrimeric G proteins are composed of 3 units; alpha,
CC       beta and gamma. The alpha chain contains the guanine nucleotide
CC       binding site (PubMed:9395396, PubMed:9417641, PubMed:10427002,
CC       PubMed:11087399, PubMed:15591060, PubMed:16766715,
CC       PubMed:19243146). Interacts with CRY1; the interaction may block
CC       GPCR-mediated regulation of cAMP concentrations. Interacts with
CC       ADCY6 and stimulates its adenylyl cyclase activity (By
CC       similarity). Interacts with ADCY2 and ADCY5 (PubMed:9395396,
CC       PubMed:9417641, PubMed:10427002, PubMed:11087399, PubMed:15591060,
CC       PubMed:16766715, PubMed:19243146). Stimulates the ADCY5 adenylyl
CC       cyclase activity (By similarity). {ECO:0000250|UniProtKB:P63092,
CC       ECO:0000269|PubMed:10427002, ECO:0000269|PubMed:11087399,
CC       ECO:0000269|PubMed:15591060, ECO:0000269|PubMed:16766715,
CC       ECO:0000269|PubMed:19243146, ECO:0000269|PubMed:9395396,
CC       ECO:0000269|PubMed:9417641}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P63094}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P63094}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Gnas-1; Synonyms=Alpha-S2;
CC         IsoId=P04896-1; Sequence=Displayed;
CC       Name=Gnas-2; Synonyms=Alpha-S1;
CC         IsoId=P04896-2; Sequence=VSP_001832;
CC       Name=Nesp55;
CC         IsoId=O18979-1; Sequence=External;
CC         Note=Shares no sequence similarity with other isoforms due to a
CC         novel first exon containing the entire reading frame spliced to
CC         shared exon 2 so that exons 2-13 make up the 3'-UTR.;
CC   -!- MISCELLANEOUS: The GNAS locus is imprinted in a complex manner,
CC       giving rise to distinct paternally, maternally and biallelically
CC       expressed proteins.
CC   -!- MISCELLANEOUS: Crystal structures were determined for GNAS in
CC       complex with an adenylyl cyclase catalytic domain that was
CC       reconstructed from ADCY2 and ADCY5 N- and C-terminal domains.
CC       {ECO:0000269|PubMed:10427002, ECO:0000269|PubMed:11087399,
CC       ECO:0000269|PubMed:15591060, ECO:0000269|PubMed:16766715,
CC       ECO:0000269|PubMed:19243146, ECO:0000269|PubMed:9395396,
CC       ECO:0000269|PubMed:9417641}.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(s) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03404; CAA27137.1; -; mRNA.
DR   EMBL; M13006; AAA30560.1; -; mRNA.
DR   EMBL; BC102905; AAI02906.1; -; mRNA.
DR   EMBL; BC122757; AAI22758.1; -; mRNA.
DR   EMBL; M14014; AAA30557.1; -; mRNA.
DR   PIR; A23818; RGBOGA.
DR   PIR; I45904; I45904.
DR   RefSeq; NP_001258700.1; NM_001271771.1.
DR   RefSeq; NP_851364.1; NM_181021.3. [P04896-1]
DR   UniGene; Bt.64619; -.
DR   UniGene; Bt.91987; -.
DR   PDB; 1AZS; X-ray; 2.30 A; C=1-394.
DR   PDB; 1AZT; X-ray; 2.30 A; A/B=1-394.
DR   PDB; 1CJK; X-ray; 3.00 A; C=1-394.
DR   PDB; 1CJT; X-ray; 2.80 A; C=1-394.
DR   PDB; 1CJU; X-ray; 2.80 A; C=1-394.
DR   PDB; 1CJV; X-ray; 3.00 A; C=1-394.
DR   PDB; 1CS4; X-ray; 2.50 A; C=1-394.
DR   PDB; 1CUL; X-ray; 2.40 A; C=1-394.
DR   PDB; 1TL7; X-ray; 2.80 A; C=1-394.
DR   PDB; 1U0H; X-ray; 2.90 A; C=1-394.
DR   PDB; 2GVD; X-ray; 2.90 A; C=1-394.
DR   PDB; 2GVZ; X-ray; 3.27 A; C=1-394.
DR   PDB; 3C14; X-ray; 2.68 A; C=1-394.
DR   PDB; 3C15; X-ray; 2.78 A; C=1-394.
DR   PDB; 3C16; X-ray; 2.87 A; C=1-394.
DR   PDB; 3G82; X-ray; 3.11 A; C=1-394.
DR   PDB; 3MAA; X-ray; 3.00 A; C=1-394.
DR   PDB; 3SN6; X-ray; 3.20 A; A=1-394.
DR   PDBsum; 1AZS; -.
DR   PDBsum; 1AZT; -.
DR   PDBsum; 1CJK; -.
DR   PDBsum; 1CJT; -.
DR   PDBsum; 1CJU; -.
DR   PDBsum; 1CJV; -.
DR   PDBsum; 1CS4; -.
DR   PDBsum; 1CUL; -.
DR   PDBsum; 1TL7; -.
DR   PDBsum; 1U0H; -.
DR   PDBsum; 2GVD; -.
DR   PDBsum; 2GVZ; -.
DR   PDBsum; 3C14; -.
DR   PDBsum; 3C15; -.
DR   PDBsum; 3C16; -.
DR   PDBsum; 3G82; -.
DR   PDBsum; 3MAA; -.
DR   PDBsum; 3SN6; -.
DR   ProteinModelPortal; P04896; -.
DR   SMR; P04896; -.
DR   CORUM; P04896; -.
DR   DIP; DIP-588N; -.
DR   IntAct; P04896; 3.
DR   STRING; 9913.ENSBTAP00000023246; -.
DR   SwissPalm; P04896; -.
DR   PaxDb; P04896; -.
DR   PRIDE; P04896; -.
DR   GeneID; 281793; -.
DR   KEGG; bta:281793; -.
DR   CTD; 2778; -.
DR   eggNOG; KOG0099; Eukaryota.
DR   eggNOG; ENOG410XPC4; LUCA.
DR   HOGENOM; HOG000038729; -.
DR   HOVERGEN; HBG063184; -.
DR   InParanoid; P04896; -.
DR   KO; K04632; -.
DR   EvolutionaryTrace; P04896; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IBA:GO_Central.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IBA:GO_Central.
DR   GO; GO:0051430; F:corticotropin-releasing hormone receptor 1 binding; IBA:GO_Central.
DR   GO; GO:0031748; F:D1 dopamine receptor binding; IBA:GO_Central.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; IBA:GO_Central.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031852; F:mu-type opioid receptor binding; IBA:GO_Central.
DR   GO; GO:0004871; F:signal transducer activity; ISS:UniProtKB.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0030819; P:positive regulation of cAMP biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0007606; P:sensory perception of chemical stimulus; IBA:GO_Central.
DR   CDD; cd00066; G-alpha; 1.
DR   Gene3D; 1.10.400.10; -; 1.
DR   InterPro; IPR000367; Gprotein_alpha_S.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; PTHR10218; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00443; GPROTEINAS.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF47895; SSF47895; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   GTP-binding; Isopeptide bond; Lipoprotein; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Transducer; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12574119}.
FT   CHAIN         2    394       Guanine nucleotide-binding protein G(s)
FT                                subunit alpha isoforms short.
FT                                /FTId=PRO_0000203717.
FT   NP_BIND      47     55       GTP. {ECO:0000305|PubMed:10427002,
FT                                ECO:0000305|PubMed:11087399,
FT                                ECO:0000305|PubMed:15591060,
FT                                ECO:0000305|PubMed:16766715,
FT                                ECO:0000305|PubMed:19243146,
FT                                ECO:0000305|PubMed:9395396,
FT                                ECO:0000305|PubMed:9417641}.
FT   NP_BIND     197    204       GTP. {ECO:0000305|PubMed:10427002,
FT                                ECO:0000305|PubMed:11087399,
FT                                ECO:0000305|PubMed:15591060,
FT                                ECO:0000305|PubMed:16766715,
FT                                ECO:0000305|PubMed:19243146,
FT                                ECO:0000305|PubMed:9395396,
FT                                ECO:0000305|PubMed:9417641}.
FT   NP_BIND     223    227       GTP. {ECO:0000305|PubMed:10427002,
FT                                ECO:0000305|PubMed:11087399,
FT                                ECO:0000305|PubMed:15591060,
FT                                ECO:0000305|PubMed:16766715,
FT                                ECO:0000305|PubMed:19243146,
FT                                ECO:0000305|PubMed:9395396,
FT                                ECO:0000305|PubMed:9417641}.
FT   NP_BIND     292    295       GTP. {ECO:0000305|PubMed:10427002,
FT                                ECO:0000305|PubMed:11087399,
FT                                ECO:0000305|PubMed:15591060,
FT                                ECO:0000305|PubMed:16766715,
FT                                ECO:0000305|PubMed:19243146,
FT                                ECO:0000305|PubMed:9395396,
FT                                ECO:0000305|PubMed:9417641}.
FT   METAL        54     54       Magnesium. {ECO:0000269|PubMed:10427002,
FT                                ECO:0000269|PubMed:11087399,
FT                                ECO:0000269|PubMed:15591060,
FT                                ECO:0000269|PubMed:19243146,
FT                                ECO:0000269|PubMed:9395396,
FT                                ECO:0000269|PubMed:9417641,
FT                                ECO:0000305|PubMed:16766715}.
FT   METAL       204    204       Magnesium. {ECO:0000269|PubMed:10427002,
FT                                ECO:0000269|PubMed:11087399,
FT                                ECO:0000269|PubMed:15591060,
FT                                ECO:0000269|PubMed:19243146,
FT                                ECO:0000269|PubMed:9395396,
FT                                ECO:0000269|PubMed:9417641,
FT                                ECO:0000305|PubMed:16766715}.
FT   BINDING     366    366       GTP; via amide nitrogen.
FT                                {ECO:0000305|PubMed:10427002,
FT                                ECO:0000305|PubMed:11087399,
FT                                ECO:0000305|PubMed:15591060,
FT                                ECO:0000305|PubMed:16766715,
FT                                ECO:0000305|PubMed:19243146,
FT                                ECO:0000305|PubMed:9395396,
FT                                ECO:0000305|PubMed:9417641}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63092}.
FT   LIPID         2      2       N-palmitoyl glycine.
FT                                {ECO:0000269|PubMed:12574119}.
FT   LIPID         3      3       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:12574119}.
FT   CROSSLNK    300    300       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P63092}.
FT   VAR_SEQ      71     84       Missing (in isoform Gnas-2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001832.
FT   CONFLICT     18     18       A -> G (in Ref. 2; AAA30560).
FT                                {ECO:0000305}.
FT   CONFLICT     85     85       D -> S (in Ref. 2; AAA30560).
FT                                {ECO:0000305}.
FT   CONFLICT    363    363       F -> S (in Ref. 2; AAA30560).
FT                                {ECO:0000305}.
FT   HELIX        36     39       {ECO:0000244|PDB:1AZT}.
FT   STRAND       40     48       {ECO:0000244|PDB:1AZS}.
FT   HELIX        53     64       {ECO:0000244|PDB:1AZS}.
FT   HELIX        87     89       {ECO:0000244|PDB:2GVZ}.
FT   HELIX        90    112       {ECO:0000244|PDB:1AZS}.
FT   STRAND      113    115       {ECO:0000244|PDB:1AZS}.
FT   HELIX       122    124       {ECO:0000244|PDB:1AZS}.
FT   HELIX       125    133       {ECO:0000244|PDB:1AZS}.
FT   TURN        134    136       {ECO:0000244|PDB:1AZS}.
FT   HELIX       144    155       {ECO:0000244|PDB:1AZS}.
FT   HELIX       157    163       {ECO:0000244|PDB:1AZS}.
FT   HELIX       164    168       {ECO:0000244|PDB:1AZS}.
FT   HELIX       175    179       {ECO:0000244|PDB:1AZS}.
FT   HELIX       182    185       {ECO:0000244|PDB:1AZS}.
FT   STRAND      187    189       {ECO:0000244|PDB:2GVZ}.
FT   HELIX       194    199       {ECO:0000244|PDB:1AZS}.
FT   STRAND      206    214       {ECO:0000244|PDB:1AZS}.
FT   STRAND      217    224       {ECO:0000244|PDB:1AZS}.
FT   HELIX       228    237       {ECO:0000244|PDB:1AZS}.
FT   TURN        238    240       {ECO:0000244|PDB:1AZS}.
FT   STRAND      243    249       {ECO:0000244|PDB:1AZS}.
FT   HELIX       252    254       {ECO:0000244|PDB:1AZS}.
FT   TURN        258    260       {ECO:0000244|PDB:1AZS}.
FT   STRAND      261    264       {ECO:0000244|PDB:2GVZ}.
FT   HELIX       265    277       {ECO:0000244|PDB:1AZS}.
FT   HELIX       280    282       {ECO:0000244|PDB:1AZT}.
FT   STRAND      283    285       {ECO:0000244|PDB:1U0H}.
FT   STRAND      287    292       {ECO:0000244|PDB:1AZS}.
FT   HELIX       294    303       {ECO:0000244|PDB:1AZS}.
FT   HELIX       308    310       {ECO:0000244|PDB:1AZS}.
FT   HELIX       313    316       {ECO:0000244|PDB:1AZS}.
FT   HELIX       332    350       {ECO:0000244|PDB:1AZS}.
FT   TURN        354    356       {ECO:0000244|PDB:1CJU}.
FT   STRAND      359    363       {ECO:0000244|PDB:1AZS}.
FT   STRAND      365    367       {ECO:0000244|PDB:3SN6}.
FT   HELIX       369    392       {ECO:0000244|PDB:1AZS}.
SQ   SEQUENCE   394 AA;  45709 MW;  4D07A734AFF2A6BC CRC64;
     MGCLGNSKTE DQRNEEKAQR EANKKIEKQL QKDKQVYRAT HRLLLLGAGE SGKSTIVKQM
     RILHVNGFNG EGGEEDPQAA RSNSDGEKAT KVQDIKNNLK EAIETIVAAM SNLVPPVELA
     NPENQFRVDY ILSVMNVPDF DFPPEFYEHA KALWEDEGVR ACYERSNEYQ LIDCAQYFLD
     KIDVIKQDDY VPSDQDLLRC RVLTSGIFET KFQVDKVNFH MFDVGGQRDE RRKWIQCFND
     VTAIIFVVAS SSYNMVIRED NQTNRLQEAL NLFKSIWNNR WLRTISVILF LNKQDLLAEK
     VLAGKSKIED YFPEFARYTT PEDATPEPGE DPRVTRAKYF IRDEFLRIST ASGDGRHYCY
     PHFTCAVDTE NIRRVFNDCR DIIQRMHLRQ YELL
//
